Latest - New Zealand drug company AFT Pharmaceuticals has made in-roads accessing the South American market.
Photo: 123RF
The maker and marketer of painkiller Maxigesic has signed a licencing agreement with a Barcelona-based company which covers Columbia, Peru and Chile.
AFT expects regulatory approvals to be completed by the end of 2021, with sales starting the following year.
The company said the market for over-the-counter pain relief in the three countries AFT will have access to is worth about $749 million.
Sharesies becomes NZX participant
That means the share buying platform will now be allowed to buy stock of individual listed companies.
Before now, Sharesies only offered shares through funds, which are made up of a mix of stock.
Sanford restructuring
The seafood company is restructuring its South Island operations, which will result in job losses in Bluff.
E tū union, the union representing the workers, said up to 30 people will lose their jobs in the proposal.
Sanford said its operations in Bluff will turn to focus on salmon and its Timaru site will focus on white fish.
Airways New Zealand criticised
The government agency which looks after civil aviation is being criticised by the global airline industry group, IATA, for big price rises.
It said Airways plans to raise its air navigation service price by nearly 13 percent from next month, with further rises due in the following two years, are disappointing and completely ignored the feedback of airlines.
IATA regional vice president Conrad Clifford said Airways New Zealand's charges will rise a total of 21 percent over three years.
He said the agency needed to control its costs and should examine the make up of its charges to see what was needed and what could be removed or deferred until later.
By contrast he said Australia's civil aviation agency has cut its charges to the tune of $20 million a year.
Mr Clifford said airlines are facing rising fuel prices and weaker world trade, and need every cost saving opportunity.
